RenovoRx, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
Mailing Address
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
Phone
408-800-2649
Fiscal Year End
1231
EIN
271448452
Financial Overview
FY2025 FY
$1.12M
Revenue
$5.42M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-3 Shelf registration for future offerings | April 16, 2026 | View on SEC |
| 4 Insider stock transaction report | April 7, 2026 | View on SEC |
| 4 Insider stock transaction report | April 7, 2026 | View on SEC |
| 4 Insider stock transaction report | April 7, 2026 | View on SEC |
| 4 Insider stock transaction report | April 7, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| 3 Initial insider ownership report | March 24, 2026 | View on SEC |
Annual Reports
10-K
March 30, 2026
- Transitioned from research to commercial operations with $1.1 million in 2025 revenue.
- Pipeline tripled to 33 U.S. cancer centers, with 12 active and 21 in evaluation.
Material Events
8-K
Financial Distress
January 2, 2026
High Impact
- RenovoRx, Inc. received a formal warning from Nasdaq for failing to meet the minimum bid price requirement of $1.00 per share.
- The company's common stock traded below $1.00 for 32 consecutive business days, putting its Nasdaq listing at risk.
Insider Trading
BUY
4 insiders
6 recent transactions
View Insider Trading Dashboard
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.